HMG20B/BRAF35 was originally identified as a factor that interacted with the BRCA2 multiprotein-complex. In association with BRCA2, HMG20B/BRAF35 plays a role in mitotic progression. HMG20B also associates with a six-subunit BRCA2-devoid complex similar to SWI/SNF and NuRD that displays deacetylating and chromatin-remodeling activity and mediates repression of neuron-specific genes.
Alternative names for
HMG20B/BRAF35 Antibody include HMG20B antibody,
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related antibody,
BRCA2-associated factor 35 antibody,
HMG box-containing protein 20B antibody,
HMG domain-containing protein 2 antibody,
HMG domain-containing protein HMGX2 antibody,
Sox-like transcriptional factor antibody,
Structural DNA-binding protein BRAF35 antibody,
high mobility group 20B antibody,
SMARCE1-related protein antibody,
high-mobility group 20B antibody,
HMG box domain containing 2 antibody,
structural DNA-binding protein BRAF35 antibody,
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E, member 1-related antibody.